Beta Bionics (BBNX) News Today $14.00 -0.50 (-3.45%) As of 01:28 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Beta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Time to Sell?Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What HappenedMarch 11 at 12:08 PM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Down 6.6% - Here's WhyBeta Bionics (NASDAQ:BBNX) Shares Down 6.6% - What's Next?March 6, 2025 | marketbeat.comBeta Bionics, Inc.'s Quiet Period To Expire on March 11th (NASDAQ:BBNX)March 6, 2025 | americanbankingnews.comBeta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Should You Sell?Beta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Should You Sell?March 5, 2025 | marketbeat.comBeta Bionics, Inc.'s Quiet Period Will Expire on March 11th (NASDAQ:BBNX)Beta Bionics' (NASDAQ:BBNX - Get Free Report) quiet period will expire on Tuesday, March 11th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. During Beta Bionics' quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.March 4, 2025 | marketbeat.comBeta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 3, 2025 | insidermonkey.comBeta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025February 27, 2025 | globenewswire.comBeta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Here's WhyBeta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - Time to Sell?February 26, 2025 | marketbeat.comLeerink Partnrs Weighs in on Beta Bionics FY2024 EarningsBeta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Investment analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Beta Bionics in a research report issued on Monday, February 24th. Leerink Partnrs analyst M. Kratky forecasts that the company will post earningsFebruary 26, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Upgraded to Strong-Buy at Leerink PartnrsLeerink Partnrs upgraded Beta Bionics to a "strong-buy" rating in a research report on Monday.February 25, 2025 | marketbeat.comBeta Bionics initiated with an Outperform at LeerinkFebruary 24, 2025 | markets.businessinsider.comBeta Bionics initiated with a Buy at BofAFebruary 24, 2025 | markets.businessinsider.comBeta Bionics (NASDAQ:BBNX) Earns Buy Rating from Analysts at Bank of AmericaBank of America initiated coverage on shares of Beta Bionics in a research note on Monday. They issued a "buy" rating on the stock.February 24, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated at Lake Street CapitalLake Street Capital began coverage on Beta Bionics in a report on Monday. They issued a "buy" rating and a $30.00 price objective on the stock.February 24, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Hold" by AnalystsShares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been assigned an average recommendation of "Hold" from the three brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating. The average 12 month priceFebruary 24, 2025 | marketbeat.comStifel Nicolaus Initiates Coverage on Beta Bionics (NASDAQ:BBNX)Stifel Nicolaus began coverage on Beta Bionics in a research note on Monday. They issued a "buy" rating and a $25.00 target price for the company.February 24, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Earns Overweight Rating from Analysts at Piper SandlerPiper Sandler started coverage on shares of Beta Bionics in a research report on Monday. They set an "overweight" rating and a $26.00 price objective for the company.February 24, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated at Leerink PartnersLeerink Partners initiated coverage on shares of Beta Bionics in a research report on Monday. They set an "outperform" rating and a $28.00 price objective on the stock.February 24, 2025 | marketbeat.comBuy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product DifferentiationFebruary 24, 2025 | tipranks.comBaird R W Upgrades Beta Bionics (NASDAQ:BBNX) to "Hold"Baird R W upgraded shares of Beta Bionics to a "hold" rating in a research note on Thursday.February 22, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - What's Next?Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Time to Sell?February 21, 2025 | marketbeat.comLADENBURG THALM/SH SH Begins Coverage on Beta Bionics (NASDAQ:BBNX)LADENBURG THALM/SH SH began coverage on Beta Bionics in a research note on Thursday. They set a "neutral" rating and a $20.00 target price for the company.February 21, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Now Covered by Robert W. BairdRobert W. Baird started coverage on shares of Beta Bionics in a report on Thursday. They issued a "neutral" rating and a $20.00 price objective for the company.February 21, 2025 | marketbeat.comBeta Bionics initiated with a Buy at LadenburgFebruary 21, 2025 | markets.businessinsider.comBeta Bionics initiated with a Neutral at BairdFebruary 20, 2025 | markets.businessinsider.comBeta Bionics rated new Neutral at Baird on valuationFebruary 20, 2025 | msn.comBeta Bionics Inc BBNXFebruary 13, 2025 | morningstar.comBeta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesFebruary 13, 2025 | finance.yahoo.comBeta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - Time to Sell?Beta Bionics (NASDAQ:BBNX) Reaches New 12-Month Low - Here's What HappenedFebruary 11, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.7% - Should You Sell?Beta Bionics (NASDAQ:BBNX) Stock Price Down 5.7% - Here's WhyFebruary 10, 2025 | marketbeat.comInsider Buying Surges in February, Especially in These 6 StocksFebruary 9, 2025 | 247wallst.comArtificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO?February 6, 2025 | msn.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Mike Mensinger Acquires 33,350 SharesFebruary 4, 2025 | insidertrades.comBeta Bionics: A Sugar Rush For This IPOFebruary 2, 2025 | seekingalpha.comBeta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesJanuary 31, 2025 | globenewswire.comBeta Bionics Aims For IPO To Cover Heavy LossesJanuary 10, 2025 | seekingalpha.com Remove Ads Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Media Mentions By Week BBNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBNX News Sentiment▼0.190.70▲Average Medical News Sentiment BBNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBNX Articles This Week▼34▲BBNX Articles Average Week Remove Ads Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Warby Parker News Today TransMedics Group News Today LivaNova News Today NovoCure News Today Enovis News Today Soleno Therapeutics News Today LeMaitre Vascular News Today CONMED News Today InMode News Today Cadre News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBNX) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
